Oncodesign establishes strategic alliance with HitGen to strengthen its Integrated Drug Discovery Service (IDDS)
Tollys closes Series A financing of €2.3 million
Accure Therapeutics launches with €7.6M Series A round
Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial
Advanced BioDesign publishes its study in non-small cell lung cancer (NSCLC) in Oncogene
Domain Therapeutics receives development milestone payment from Merck KGaA, Darmstadt, Germany, for collaboration on adenosine receptor antagonists
Nosopharm obtains US patent for NOSO-502, a first-in-class novel antibiotic
Calixar launches new funding round to establish business strategy
